Indianapolis LASIK Specialists Blog of Price Vision Group

Price Vision Group Becomes First in Indiana to Treat Degenerative Corneal Disease, Neurotrophic Keratitis, with New FDA-Approved Drug

Posted on February 14, 2019 by Sam Ven

Indianapolis, IN – Dr. Matthew Feng of Price Vision Group will be the first ophthalmologist in Indiana to use the new FDA-approved drug, Oxervate™ (cenegermin). The patient, Tina Hunter, has vision loss due to neurotrophic keratitis (NK). NK is a rare, degenerative corneal disease for which previous treatments include artificial tears or autologous serum tears, which are custom made from a patient’s…

How Does Cornea Thickness Affect My Candidacy For LASIK?

Posted on January 16, 2019 by Sam Ven

When a patient comes to our office for a LASIK screening, one of the first things we check for is cornea thickness. So why is cornea thickness important for LASIK? During LASIK, an excimer laser is used to remove tissue (ablation) and reshape the cornea so images can focus accurately onto the retina. Since corneal tissue is permanently removed during the LASIK procedure,…

Price Vision Group to Become First in US to Perform LIKE Procedure

Posted on December 20, 2018 by Sam Ven

Pioneering cornea surgeon Francis W. Price, Jr., MD of Price Vision Group in Indianapolis, IN is scheduled to become the first in the U.S. to perform the revolutionary LIKE procedure. LIKE (LASIK and Intrastromal Keratoplasty) is the next generation in refractive surgery to correct extreme farsightedness in people who cannot be helped by current LASIK or refractive techniques. Clear, focused vision depends on…

Price Vision Group Becomes First in Indiana to Implant Visian Toric ICL

Posted on December 19, 2018 by Sam Ven

Indianapolis, IN, November 8, 2018 – Price Vision Group is the first practice in Indiana to implant the new FDA-approved Visian Toric ICL from STAAR Surgical. This new implantable collamer lens (ICL) provides a new solution for patients with moderate to high levels of myopia and astigmatism ‒ in one simple procedure. Previously, ICL patients with astigmatism would need a separate LASIK…

FDA Approves Visian Toric ICL for astigmatism. What it means.

Posted on September 20, 2018 by Sam Ven

On September 13, 2018, STAAR Surgical announced the approval by the FDA of the Visian Toric ICL (TICL) for the correction of myopia with astigmatism. Before the announcement, the Visian ICL (implantable collamer lens) product line in the United States only consisted of lenses that offer correction for patients with myopia (nearsightedness). Visian ICL patients with astigmatism would require an…

Dr. Francis W. Price, Jr. to Receive Thomas C. Hasbrook Award

Posted on October 30, 2017 by Sam Ven

INDIANAPOLIS—Bosma Enterprises, an Indianapolis-based nonprofit organization dedicated to creating opportunities for Hoosiers who are blind or visually impaired, is set to honor two prominent supporters at its annual Hasbrook Awards Luncheon. The event will be held Nov. 2 at The Crane Bay, 551 W. Merrill St., Indianapolis, to raise funds for employment and training programs. During the luncheon, Bosma will…

Price Vision Group to Participate in National Sight Week

Posted on October 6, 2017 by Sam Ven

Price Vision Group to Participate in National Sight Week Local Eye Surgeons Will Provide Free Cataract Surgery Indianapolis, IN – Price Vision Group is pleased to announce its participation in the 2nd annual National Sight Week (October 15-21), sponsored by the American Society of Cataract & Refractive Surgery (ASCRS) Foundation. During National Sight Week, Dr. Francis Price, Jr, Dr.…

Advancements in Cell Regeneration Not Yet as Reliable as DMEK in Fuchs’ dystrophy

Posted on September 25, 2017 by Sam Ven

Advancements in Cell Regeneration Not Yet as Reliable as DMEK in Fuchs’ dystrophy By Francis W. Price, Jr., MD & Matthew T. Feng, MD We are always looking for better ways to correct the visual difficulties of patients with Fuchs’ dystrophy. In fact, that is why we helped pioneer the evolution of corneal transplants from full thickness grafts (penetrating keratoplasty)…

Dr. Francis Price, Jr. Performs First XEN® Gel Stent Procedure in Indiana on Glaucoma Patient

Posted on August 11, 2017 by Sam Ven

Indianapolis, IN – August 4, 2017 – Dr. Francis Price Jr., of the Price Vision Group and one of the top cornea specialists in the world, added another “first” to his distinguished credentials in the field of ophthalmology. Having been the first in the state of Indiana to perform several refractive surgeries such as LASIK, all-laser LASIK and CONTOURA™ Vision…

Dr. Matthew T. Feng: One to Watch!

Posted on March 7, 2016 by Greg Rader

Matthew T. Feng, MD has been profiled as “One to Watch” by MillennialEYE Magazine! Dr. Feng is a cataract, LASIK, and corneal transplant surgeon at Price Vision Group. The distinction recognizes a “rising star” in ophthalmology. Congratulations, Dr. Feng! You can read the article right now by Clicking here.

Price Vision Group Blog

Price Vision Group Becomes First in Indiana to Treat Degenerative Corneal Disease, Neurotrophic Keratitis, with New FDA-Approved Drug

How Does Cornea Thickness Affect My Candidacy For LASIK?

Price Vision Group to Become First in US to Perform LIKE Procedure

Price Vision Group Becomes First in Indiana to Implant Visian Toric ICL

FDA Approves Visian Toric ICL for astigmatism. What it means.

Dr. Francis W. Price, Jr. to Receive Thomas C. Hasbrook Award

Price Vision Group to Participate in National Sight Week

Advancements in Cell Regeneration Not Yet as Reliable as DMEK in Fuchs’ dystrophy

Dr. Francis Price, Jr. Performs First XEN® Gel Stent Procedure in Indiana on Glaucoma Patient

Dr. Matthew T. Feng: One to Watch!

Contact Us

DO NOT USE THIS FORM IF YOU HAVE AN URGENT NEED TO BE SEEN. CALL OUR OFFICE.